PHARMACEUTICAL INNOVATION BY THE 7 UK-OWNED PHARMACEUTICAL COMPANIES (1964-1985)

被引：356
|
作者：
PRENTIS, RA
LIS, Y
WALKER, SR
机构：
来源：
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 1988年 / 25卷 / 03期
关键词：
D O I：
10.1111/j.1365-2125.1988.tb03318.x
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：387 / 396
页数：10
相关论文
共 50 条
  • [31] The relationship between virtuous leadership and innovation management in the pharmaceutical companies of the public business sector - Egypt
    Mohammed, Sanaa Mostafa
    El-Ashram, Reda Ebrahim
    INTERNATIONAL JOURNAL OF INNOVATION SCIENCE, 2025, 17 (01) : 1 - 18
  • [32] Contribution of Pharmaceutical Innovation to Longevity Growth in Germany and France, 2001-7
    Lichtenberg, Frank R.
    PHARMACOECONOMICS, 2012, 30 (03) : 197 - 211
  • [33] Economic policy uncertainty and corporate innovation-empirical evidence from Chinese pharmaceutical listed companies
    Wu, Zikun
    Wang, Su
    Kuang, Licong
    Chen, Yuwen
    FRONTIERS IN PUBLIC HEALTH, 2025, 12
  • [34] Augmenting learning processes of absorptive capacity for innovation: Insights for effective leadership within global pharmaceutical companies
    Rezaei Zadeh, Mohammad
    Hackney, Ray
    Zeng, Jing
    EUROPEAN MANAGEMENT REVIEW, 2022, 19 (02) : 263 - 284
  • [35] UNILATERAL RESTRICTIONS OF PARALLEL TRADE BY DOMINANT PHARMACEUTICAL COMPANIES - PROTECTION OF INNOVATION OR ANTI-COMPETITIVE MARKET FORECLOSURE?
    Wurmnest, Wolfgang
    RABELS ZEITSCHRIFT FUR AUSLANDISCHES UND INTERNATIONALES PRIVATRECHT, 2009, 73 (04): : 962 - 984
  • [36] Corporate financialization, financing constraints, and innovation efficiency-Empirical evidence based on listed Chinese pharmaceutical companies
    Zhu, Jialin
    Tang, Yaning
    Wei, Yanyi
    Wang, Su
    Chen, Yuwen
    FRONTIERS IN PUBLIC HEALTH, 2023, 11
  • [37] DEVELOPING A TOOL FOR MEASURING KNOWLEDGE ABSORPTIVE CAPACITY AND ASSESSING ITS EFFECT ON INNOVATION PERFORMANCE OF IRANIAN PHARMACEUTICAL COMPANIES
    Sanati, Ehsan
    Varahrami, Vida
    Davari, Majid
    Keshavarz, Khosro
    Abdollahiasl, Akbar
    Madani, Hessamdin
    Kebriaeezade, Abbas
    INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH, 2018, 9 (07): : 3075 - 3082
  • [38] THE IMPACT OF CORPORATE SOCIAL RESPONSIBILITY ON FIRM PERFORMANCE WITH MEDIATING EFFECT OF INNOVATION; EVIDENCE FROM PHARMACEUTICAL COMPANIES OF THAILAND
    Park, Tiwa
    INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2019, 6 (01): : 540 - 545
  • [39] Health research and innovation: Can we optimize the interface between startups/pharmaceutical companies and academic health care institutions or not?
    Dhainaut, Jean-Francois
    Blin, Olivier
    Herry, Florence
    Benito, Sylvain
    Bilbault, Pascal
    Cauterman, Maxime
    Favrel-Feuillade, Florence
    Fazi-Leblanc, Stephanie
    Germain, Caroline
    Goehrs, Clement
    Grosskopf, Cecile
    Labarthe, Benoit
    Lechat, Philippe
    Malciu, Corneliu
    Marquet, Pierre
    Miceli-Richard, Corinne
    Peyret, Olivier
    Rattenbach, Revital
    de Saint-Exupery, Edouard
    THERAPIE, 2020, 75 (01): : 113 - 123
  • [40] The role of geographic location in the financial and innovation performance of publicly traded pharmaceutical companies: empirical evidence from the United States
    Boasson, V
    MacPherson, A
    ENVIRONMENT AND PLANNING A, 2001, 33 (08) : 1431 - 1444
12345